Media
April 15, 2025: Le Journal des biotechs : Hervé Affagard (Maat Pharma), Frédéric Gomez (Pharmium Securities) – Boursorama (French Only)
Date : 15/04/2025
We are a clinical-stage microbiome therapeutics company aiming to improve survival in cancer.
© 2025 MaaT Pharma. MaaT Pharma’s mission is to restore microbiome function to treat life-threatening diseases
